First, medical representation is similar to equipment sales. Can be classified as marketing personnel. In contrast, it is best to divide the sales of medical devices into the sales of consumables and small equipment and the sales of medium and large equipment. In terms of difficulty, consumables are the easiest, followed by drugs, and equipment is the most difficult. Large-scale equipment has more relations and more complicated procedures, because the amount of funds is large and cannot be decided by a small location. Among drugs, tumor drugs are the most difficult. In terms of income, large-scale equipment is the most profitable, and there is little difference between consumables and medicines. It depends on the grade of consumables or medicines you sell. Of course, foreign companies or agents have more money to import or own some monopoly products. Drugs such as cancer, cardiovascular disease and diabetes have higher profits. Pharmacokinetics and device sales are both situations that require a lot of investment in the early stage and earn more money when the market matures. Of course, some people can't insist on opening the market, or they can't mature the market. There is a lot of room for transfer and promotion. If a truly capable person does not have the trouble of finding a job. There are still many people who start from sales and go it alone as bosses. The entry threshold of sales category is lower, but foreign companies value it more. Mainly for pharmaceutical companies, equipment manufacturers or agency companies. The rigid demand for products is not easily affected by the financial crisis.
Secondly, CRA should not expect to make a lot of money. A little pedantic. At present, people who generally need clinical, nursing, medical or pharmaceutical majors are recruited. A better company requires work experience, and foreign companies must pass Grade 6. High liquidity. The pressure is less than sales, but the money is also less, and the entry threshold is slightly higher. Many people think this is a promising industry. There is relatively little room for job-hopping and promotion. Mainly for CRO and pharmaceutical companies. The nature of service is stronger, in contrast, the financial crisis has a greater impact.